NICOLE BOWERS: Open Payments
NPI 1942841499 · NAPERVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,119 in 155 payments from 21 companies in 2025. Trend: 2023 $1,520 · 2024 $2,891 · 2025 $3,119
Food & beverage: $3,002Education: $116
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $375 |
| Otsuka America Pharmaceutical, Inc. | 18 | $350 |
| Axsome Therapeutics, Inc. | 7 | $272 |
| Vanda Pharmaceuticals Inc. | 8 | $258 |
| Neurocrine BioSciences, Inc. | 11 | $219 |
| Teva Pharmaceuticals USA, Inc. | 11 | $215 |
| Corium, LLC | 14 | $181 |
| Janssen Pharmaceuticals, Inc | 10 | $181 |
| Tris Pharma Inc | 9 | $164 |
| E.R. Squibb & Sons, L.L.C. | 7 | $156 |
Products named: VRAYLAR, REXULTI, FANAPT, Auvelity, INGREZZA, Azstarys, Dyanavel XR, COBENFY.
Industry payments across IL — which companies pay providers there.
